The Therakind Team

• Dr Susan Conroy has been involved in The Therakind project since its inception. She is an experienced pharmaceutical manager, specialising in the identification, evaluation, management and commercialisation of pharmaceutical and biotechnology projects
• With a PhD in Molecular Biology and post-doctoral research in oncology at University College London, Susan moved into industry
• Following several years of clinical trial work she moved into evaluating and commercialising potential and existing research/development projects in multiple pharmaceutical areas
• She then became a self-employed consultant specialising in maximising scientific value to early start up programmes and an independent funding assessor of university start-up projects, prior to establishing Therakind

• Jackie has some 30 years experience in the pharmaceutical industry including 25 years in regulatory affairs
• She worked for 10 years in the Global Regulatory Affairs Department of a major multinational pharmaceutical company, where she was responsible for worldwide product registration, before moving to work for smaller pharmaceutical companies.
• Jackie is experienced in defining worldwide regulatory strategy, product development planning, coordinating and directing the preparation and review of worldwide regulatory submissions and establishing effective working relationships both within and outside the company
• She has considerable knowledge of EU/US licensing procedures and pharmaceutical regulations, directives and guidelines including those relating to paediatrics
• Her extensive experience covers a large number of therapeutic areas and all stages of product development

• Louise has over 18 years’ experience in the pharmaceutical industry within regulatory affairs and regulatory compliance.
• She has experience in managing compliance programmes for global clinical trials.
• Louise has facilitated regulatory authority inspections of both UK- and US-based investigator sites and GMP and device manufacturing facilities.
• She has considerable knowledge of EU/US clinical trial regulations as well as medical device licensing procedures and regulations, directives and guidelines.
• Her extensive experience covers all phases of clinical trials.
• Louise also has 10 years’ experience in pharmacovigilance for licensed and investigational medicinal products.

• Dr Mulla qualified as a pharmacist and subsequently practiced as a hospital clinical pharmacist for a number of years before moving to specialising in adult and paediatric intensive care.
• Following completion of a PhD in pharmacokinetics in children, Hussain moved to industry in Astra Zeneca. Here Hussain worked in the Department of Experimental Medicine and Clinical Pharmacology on early phase (first time in man) studies. This included pharmacokinetic / pharmacodynamic, population modelling and biopharmaceutics.
• In 2006 Hussain returned to the University Hospital of Leicester as a research pharmacist and became the Co-Director for the Centre of Therapeutic Evaluations of Drugs in Children.
• Hussain is experienced in all areas of population PK/PD modelling, formulation development, safety and tolerability of excipients as well as appropriate microanalytical methodologies for facilitating paediatric studies.
• Hussain is considered an expert in the field of paediatric studies.

Helen has been involved in various aspects of clinical development and clinical trials for over 15 years. Helen's experience includes:

• the design of clinical development programmes,
• preparation of clinical research documentation,
• conduct of clinical programmes,
• management of clinical research staff and investigators,
• site selection, ethics documentation,
• site management and monitoring and presentation of clinical data.

Helen has a Ph.D in neuroscience.

• Dr Neubert qualified as a pharmacist in Germany and then worked as a clinical research associate before undertaking a PhD in Paediatric Clinical Pharmacy from the FAU Erlangen/Nuremberg, Germany.
• In 2006 she joined the Centre for Paediatric Pharmacy Research at the School of Pharmacy as a research Fellow, where she became the UK scientific coordinator of the "Task Force in Europe for Drug Development for the Young" (TEDDY), a project funded by the EU to promote and improve paediatric medicines research.
• She was also involved in various paediatric projects commissioned by the UK Department of Health and the National Patient Safety Agency (NPSA).
• At Therakind she provides her paediatric scientific and academic experience from conducting observational studies and is involved in all aspects of the clinical programmes.

• Until December 2003, Nick was Head of Life Sciences and Joint Head of Corporate Finance at Evolution Securities (formerly Beeson Gregory)
• In that role he advised on a large number of initial public offerings, fundraisings, acquisitions, mergers, disposals and takeovers dealing with both private and public companies
• Whilst at Beeson Gregory, he was heavily involved in the establishment of IP Group plc’s first two partnerships and was a member of the steering committee for the Oxford partnership and the investment committee for the Southampton partnership
• Nick has been involved in helping companies at most stages of their development as well as sitting on boards of both public and private companies
• Nick is the chief executive of IPSO Ventures, the early investor of Therakind

• Professor Wong is the Professor of Paediatric Medicines Research and the Director of the Centre for Paediatric Pharmacy Research at The School of Pharmacy in London
• He is a qualified pharmacist and worked at the former UK Medicines Control Agency before starting his research career in medication safety
• Professor Wong took up a research pharmacist post at the David Lewis Centre for Epilepsy to investigate the safety of new anti-epileptic drugs between 1994 and 1997 and was awarded his PhD from Manchester Medical School
• In 1997, Professor Wong was appointed as a lecturer at the University of Bradford before moving to The School of Pharmacy, University of London, to set up the Centre for Paediatric Pharmacy Research
• He was awarded a Department of Health Public Health Career Scientist Award in 2002
• Professor Wong and his colleagues also received the Neonatal and Paediatric Pharmacists Group Award in 2003 and Chemists and Druggists Pharmacy Practice Research Medal 2004 for his research in paediatric medicines
• To date he has published over 200 publications

• Professor Anthony Smith is Principal and Dean of the School of Pharmacy, University of London
• He is a fellow of the Higher Education Academy and the Royal Pharmaceutical Society, Chair of the Council of University Heads of Pharmacy (CUHOP) and a member of the Royal Pharmaceutical Society’s Adjudicating Committee, Accreditation Team and Education Committee
• As a member of Universities-UK, he sits on UUK’s Health and Social Care Policy Committee.
• He served on the Medicines and Healthcare Regulatory Authority Chemistry, Pharmacy and Standards Expert Advisory Group from 2007-2009.

• Professor David Latchman is Master of Birkbeck College, University of London and Professor of Genetics at Birkbeck and University College, London
• Professor Latchman has a first class honours BA in Natural Sciences, specialising in Genetics, a PhD and a DSc and has published extensively in the field of Genetics and Molecular Biology
• He was appointed to the Chair of Human Genetics at UCL and Dean of the Institute of Child Health in 1999
• Professor Latchman has an impressive track record as a fund-raiser, raising over £9 million pounds whilst Dean at the Institute of Child Health
• On the basis of patents developed by his laboratory and with his significant experience of the commercial exploitation of intellectual property, he obtained Venture Capital funding to found a Company (Bio Vex Ltd)
• Professor Latchman serves on a variety of committees, is “Chair of London Higher”, a representative ‘umbrella’ organisation for universities and higher education colleges in London and was appointed by the Mayor of London to serve on the London Skills and Employment Board and promote London Council. He is also patron of “Women and Children First”, a UK registered charity working to improve maternal and newborn health in poor communities and particularly in developing countries